The FDA is allowed to visit your company to perform an inspection. In the course of the visit they may bring some issue to your attention in the form of an observation (aka a 483). This article reviews what a 483 looks like, some of the more common issues flagged in medical device companies, and how to respond.
We invite you to download our paper on the topic of 483 Observations.
Product teams all have the same goal: produce high-quality products and reduce time to market. Achieving these goals simultaneously can be difficult, but your team doesn’t have to sacrifice one for the other. Learn how in this eBook.What You Will Learn In this eBook,...
Challenges Increased market demands and need for real-time global collaboration Insufficient Product Data Management (PDM) system for the scale and complexity of operations Need to translate a single EBOM into accurate MBOMs across global locations Increasingly...
Key Takeaways Audit failures often stem from incomplete records, disconnected systems, weak controls, and manual processes. Continuous traceability helps teams capture compliance evidence as part of everyday engineering work. Connecting ALM and PLM creates clearer...
Product teams all have the same goal: produce high-quality products and reduce time to market. Achieving these goals simultaneously can be difficult, but your team doesn’t have to sacrifice one for the other. Learn how in this eBook.What You Will Learn In this eBook,...